BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 9370197)

  • 1. Estrogen modulation of opioid and cholecystokinin systems in the limbic-hypothalamic circuit.
    Micevych PE; Eckersell CB; Brecha N; Holland KL
    Brain Res Bull; 1997; 44(4):335-43. PubMed ID: 9370197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opiate receptors modulate estrogen-induced cholecystokinin and tachykinin but not enkephalin messenger RNA levels in the limbic system and hypothalamus.
    Eckersell CB; Micevych PE
    Neuroscience; 1997 Sep; 80(2):473-85. PubMed ID: 9284350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infusion of CCK-A receptor mRNA antisense oligodeoxynucleotides inhibits lordosis behavior.
    Holland KL; Popper P; Micevych PE
    Physiol Behav; 1997 Sep; 62(3):537-43. PubMed ID: 9272661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripubertal ontogeny and estrogen stimulation of cholecystokinin and preproenkephalin mRNA in the rat hypothalamus and limbic system.
    Holland KL; Norby LA; Micevych PE
    J Comp Neurol; 1998 Mar; 392(1):48-57. PubMed ID: 9482232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of CCK mRNA levels in the limbic-hypothalamic circuit: time course and site-specific effects of estrogen.
    Micevych P; Eckersell CB; Holland K; Smith A
    J Neurobiol; 1996 Aug; 30(4):465-79. PubMed ID: 8844510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of delta-opioid receptors reduces the in vivo binding of the cholecystokinin (CCK)-B-selective agonist [3H]pBC 264: evidence for a physiological regulation of CCKergic systems by endogenous enkephalins.
    Ruiz-Gayo M; Durieux C; FourniƩ-Zaluski MC; Roques BP
    J Neurochem; 1992 Nov; 59(5):1805-11. PubMed ID: 1357099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen-induced alteration of mu-opioid receptor immunoreactivity in the medial preoptic nucleus and medial amygdala.
    Eckersell CB; Popper P; Micevych PE
    J Neurosci; 1998 May; 18(10):3967-76. PubMed ID: 9570823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of the limbic-hypothalamic cholecystokinin circuit: a model of sexual differentiation.
    Micevych P; Ulibarri C
    Dev Neurosci; 1992; 14(1):11-34. PubMed ID: 1600878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCK-B receptors in the limbic system modulate the antidepressant-like effects induced by endogenous enkephalins.
    Smadja C; Ruiz F; Coric P; FourniƩ-Zaluski MC; Roques BP; Maldonado R
    Psychopharmacology (Berl); 1997 Aug; 132(3):227-36. PubMed ID: 9292622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of thyroxine and estrogen on the expression of estrogen receptor alpha, cholecystokinin, and preproenkephalin messenger ribonucleic acid in the limbic-hypothalamic circuit.
    Holland K; Norell A; Micevych P
    Endocrinology; 1998 Mar; 139(3):1221-8. PubMed ID: 9492057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen and endogenous opioids regulate CCK in reproductive circuits.
    Micevych P; Sinchak K
    Peptides; 2001 Aug; 22(8):1235-44. PubMed ID: 11457516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medial preoptic area delta-opioid receptors inhibit lordosis.
    Sinchak K; Mills RH; Eckersell CB; Micevych PE
    Behav Brain Res; 2004 Dec; 155(2):301-6. PubMed ID: 15364490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of an intrahypothalamic injection of antisense oligonucleotides for preproenkephalin mRNA in female rats: evidence for opioid involvement in lordosis reflex.
    Nicot A; Ogawa S; Berman Y; Carr KD; Pfaff DW
    Brain Res; 1997 Nov; 777(1-2):60-8. PubMed ID: 9449413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of enkephalin catabolism inhibitors and CCK-B antagonists: a potential use in the management of pain and opioid addiction.
    Roques BP; Noble F
    Neurochem Res; 1996 Nov; 21(11):1397-410. PubMed ID: 8947930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of mu-opioid receptors inhibits lordosis behavior in estrogen and progesterone-primed female rats.
    Acosta-Martinez M; Etgen AM
    Horm Behav; 2002 Feb; 41(1):88-100. PubMed ID: 11863387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gonadal steroid control of preprocholecystokinin mRNA expression in the limbic-hypothalamic circuit: comparison of adult with neonatal steroid treatments.
    Micevych PE; Abelson L; Fok H; Ulibarri C; Priest CA
    J Neurosci Res; 1994 Jul; 38(4):386-98. PubMed ID: 7932871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microinjection of cholecystokinin into the medial preoptic nucleus facilitates lordosis behavior in the female rat.
    Dornan WA; Bloch GJ; Priest CA; Micevych PE
    Physiol Behav; 1989 May; 45(5):969-74. PubMed ID: 2780882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptor-alpha is required for estrogen-induced mu-opioid receptor internalization.
    Micevych PE; Rissman EF; Gustafsson JA; Sinchak K
    J Neurosci Res; 2003 Mar; 71(6):802-10. PubMed ID: 12605406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen and CCK1 receptor modification of mu-opioid receptor binding in the cortex of female rats.
    Quesada A; Micevych P
    Brain Res; 2006 Feb; 1073-1074():316-20. PubMed ID: 16472782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gonadal steroid hormones and hypothalamic opioid circuitry.
    Hammer RP; Zhou L; Cheung S
    Horm Behav; 1994 Dec; 28(4):431-7. PubMed ID: 7729811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.